Dr. Seth Kindler M.D
Expertise
For the past 20 years, I have been involved with all aspects of clinical research and development of synthetic and natural cannabinoid-based therapies.
My extensive experience in the field of cannabinoid-based drug development began with my role as Medical Director at Pharmos LTD., based in Rehovot Israel. Pharmos was developing synthetic cannabinoid agonists for the mitigation of CNS damage following trauma or hypoxia.
Development, management and implementation of product strategy and planning from pre-clinical development till phase III clinical studies.
Research &Development, clinical and regulatory processes to ensure effective and timely product development and introduction.
Education
-
M.D., Hadassah Medical School Hebrew University, Jerusalem, Israel, 1982
-
Psychiatry, Psychiatric Division Ezrath Nashim Hospital Jerusalem, Israel, 1990
-
Lecturer in Psychiatry, Sackler Medical School, Tel-Aviv, Israel, 1995
Membership in professional societies
-
Israel Psychiatric Association
-
Israel Medical Association
-
Society for Neuroscience
-
International Cannabinoid Research Society
Positions
1985-1990 Psychiatry residency, Psychiatric Division Ezrath Nashim Hospital Jerusalem, Israel
1990-1995 Lecturer in Psychiatry, Sackler Medical School, Tel-Aviv, Israel,
1997-1999 Medical Director, Bristol-Myers Squibb Israel, Peta Tikva, Israel,
1999-2002 Medical Director, Gamida Cell, Jerusalem, Israel
2002-2007 Medical Director, Pharmos LTD. Rehovot, Israel,
2008-2009 Medical Consultant, GliaMed Inc, Ma, USA
2010-2016 Chief Scientific officer, Syqe Medical​
Employment
1990-1992 Head of Panic Disorder Unit, Tel-Hashomer Hospital
1992-1994 Deputy Head of Psychiatric In-Patient Unit, Tel-Hashomer, Hospital
1990-1992 Head of PTSD Research unit, Israeli Medical Corps
1989-1990 Head of Brain Research unit, Herzog Hospital, Jerusalem, Israel